Literature DB >> 29345060

Porcine NK cells display features associated with antigen-presenting cells.

Steffi De Pelsmaeker1, Bert Devriendt1, Georges Leclercq2, Herman W Favoreel1.   

Abstract

NK cells are members of the innate immunity and play a central role in the defense against viral infections and cancer development, but also contribute to triggering and shaping adaptive immune responses. Human NK cells may express MHC II and costimulatory molecules, including CD86, CD80, and OX40 ligand, which allows them to stimulate the CD4+ T-cell response. In contrast, murine NK cells do not express MHC II or costimulatory molecules. Upon activation, mouse NK cells can acquire these molecules from dendritic cells (DCs) via intercellular membrane transfer, which leads to suppression of DC-induced CD4+ T-cell responses rather than stimulation of T-cell responses. Previous studies showed that porcine NK cells can express MHC II molecules, but it was unknown if porcine NK cells also express costimulatory molecules and whether NK cells may affect T-cell proliferation. We found that primary porcine NK cells express functional MHC II molecules and costimulatory CD80/86, particularly upon activation with IL-2/IL-12/IL-18, and that they are able to stimulate T-cell proliferation. In addition, we show that porcine NK cells are able to internalize antigens derived from killed target cells in an actin polymerization-dependent process. All together, these results indicate that porcine NK cells possess properties associated with APCs, which allows them to stimulate T-cell proliferation. ©2017 Society for Leukocyte Biology.

Entities:  

Keywords:  APC; NK cells; pig

Mesh:

Year:  2017        PMID: 29345060     DOI: 10.1002/JLB.4A0417-163RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

2.  Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.

Authors:  Steffi De Pelsmaeker; Evelien Dierick; Barbara Klupp; Thomas C Mettenleiter; Claudia Cantoni; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 3.  Non-murine models to investigate tumor-immune interactions in head and neck cancer.

Authors:  Carlos Rossa; Nisha J D'Silva
Journal:  Oncogene       Date:  2019-03-14       Impact factor: 9.867

4.  CD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity.

Authors:  Roman V Uzhachenko; Anil Shanker
Journal:  Front Immunol       Date:  2019-08-13       Impact factor: 7.561

5.  Identification of a Porcine Liver EomeshighT-betlow NK Cell Subset That Resembles Human Liver Resident NK Cells.

Authors:  Steffi De Pelsmaeker; Sofie Denaeghel; Leen Hermans; Herman W Favoreel
Journal:  Front Immunol       Date:  2019-10-31       Impact factor: 7.561

6.  β-Glucan-Induced IL-10 Secretion by Monocytes Triggers Porcine NK Cell Cytotoxicity.

Authors:  Leen Hermans; Steffi De Pelsmaeker; Sofie Denaeghel; Eric Cox; Herman W Favoreel; Bert Devriendt
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 7.  Adaptive Cellular Immunity against African Swine Fever Virus Infections.

Authors:  Alexander Schäfer; Giulia Franzoni; Christopher L Netherton; Luise Hartmann; Sandra Blome; Ulrike Blohm
Journal:  Pathogens       Date:  2022-02-20

8.  Cyberlindnera jadinii Yeast as a Protein Source for Weaned Piglets-Impact on Immune Response and Gut Microbiota.

Authors:  Leidy Lagos; Alexander Kashulin Bekkelund; Adrijana Skugor; Ragnhild Ånestad; Caroline P Åkesson; Charles McL Press; Margareth Øverland
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

9.  Porcine NK Cells Stimulate Proliferation of Pseudorabies Virus-Experienced CD8+ and CD4+CD8+ T Cells.

Authors:  Steffi De Pelsmaeker; Bert Devriendt; Nick De Regge; Herman W Favoreel
Journal:  Front Immunol       Date:  2019-01-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.